Multiple Sclerosis | |
|---|---|
| Study Name | Principal Investigator |
| MN43964 – A Multicenter, Single-Arm, Open-Label, Extension, Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab of in Patients with Multiple Sclerosis. Read more. |
Mary Ann Picone, MD |
| 23-15 HN – Pilot Study to Determine the Effectiveness of the ‘Prescription for Wellness’ for Patients With Multiple Sclerosis. |
Asya Wallach, MD |
| GN41791 – A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared with Ocrelizumab in Adult
Patients with Primary Progressive Multiple Sclerosis (FENtrepid). Read more. |
Asya Wallach, MD |
| ICP-CL-00112 – A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Orelabrutinib in Patients with Relapsing-Remitting Multiple Sclerosis to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Biological Activity. Read more. |
Mary Ann Picone, MD |
